نتایج جستجو برای: implantable cardioverter

تعداد نتایج: 18451  

2014
Teri M. Kozik Gianna Chien Therese F. Connolly Gurinder S. Grewal David Liang Walter Chien

BACKGROUND Over 140 million iPads(®) have been sold worldwide. The iPad2(®), with magnets embedded in its frame and Smart Cover and 3G cellular data capability, can potentially cause electromagnetic interference in implantable cardioverter defibrillators. This can lead to potentially life-threatening situations in patients. The goal of this study was to determine whether the iPad2(®) can cause ...

2010
Roberto F.E. Pedretti Antonio Curnis Riccardo Massa Fabrizio Morandi Massimo Tritto Lorenzo Manca Eraldo Occhetta Giulio Molon Gaetano M. De Ferrari Simona Sarzi Braga Giovanni Raciti Catherine Klersy

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CLINICAL RESEARCH Implantable Cardi...

2017
Mitsuhiro Fukata Takeshi Arita Hideki Kadota Keita Odashiro Toru Maruyama Koichi Akashi

Introduction A subcutaneous implantable cardioverter-defibrillator (S-ICD) is now being used as an alternative to a transvenous implantable cardioverter-defibrillator (TV-ICD). Because the location of the device in the body differs between S-ICD and TV-ICD, ICD-related complications need to be managed in a device-specific manner. Therefore, therapeutic strategies for infected wounds may differ ...

2016
Yusuke Kondo Marehiko Ueda Yoshio Kobayashi Joerg O. Schwab

There has been a significant increase in the number of patients receiving cardiovascular implantable electronic devices (CIED) over the last two decades. CIED infection represents a serious complication after CIED implantation and is associated with significant morbidity and mortality. Recently, newly advanced technologies have offered attractive and suitable therapeutic alternatives. Notably, ...

2017
Mohammad-Ali Jazayeri Martin P. Emert JoAnn Bartos Ted Tabbert Dhanunjaya R. Lakkireddy Mohammad-Reza Jazayeri

Introduction The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a safe and effective treatment for prevention of sudden cardiac death. It is typically not used in patients who require additional therapies conferred by transvenous implantable cardioverter-defibrillator (TV-ICD) systems, such as bradycardia pacing or antitachycardia pacing (ATP) for ventricular tachycardia (VT). D...

2017
Marcello Disertori Michela Masè Marta Rigoni Giandomenico Nollo Eloisa Arbustini Flavia Ravelli

Citation: Disertori M, Masè M, Rigoni M, Nollo G, Arbustini E and Ravelli F (2017) Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients. Front. Physiol. 8:873. doi: 10.3389/fphys.2017.00873 Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-T...

Journal: :Circulation 2013
Frédéric Sacher Vincent Probst Philippe Maury Dominique Babuty Jacques Mansourati Yuki Komatsu Christelle Marquie Antonio Rosa Abou Diallo Romain Cassagneau Claire Loizeau Raphael Martins Michael E Field Nicolas Derval Shinsuke Miyazaki Arnaud Denis Akihiko Nogami Philippe Ritter Jean-Baptiste Gourraud Sylvain Ploux Anne Rollin Adlane Zemmoura Dominique Lamaison Pierre Bordachar Bertrand Pierre Pierre Jaïs Jean-Luc Pasquié Mélèze Hocini François Legal Pascal Defaye Serge Boveda Yoshito Iesaka Philippe Mabo Michel Haïssaguerre

BACKGROUND Implantable cardioverter-defibrillator indications in Brugada syndrome remain controversial, especially in asymptomatic patients. Previous outcome data are limited by relatively small numbers of patients or short follow-up durations. We report the outcome of patients with Brugada syndrome implanted with an implantable cardioverter-defibrillator in a large multicenter registry. METH...

2015
Hamid Ghanbari Brahmajee K. Nallamothu Yongfei Wang Jeptha P. Curtis

BACKGROUND Management of antithrombotic agents after implantable cardioverter defibrillator implantation is challenging, particularly among patients with atrial fibrillation and coronary artery disease. METHODS AND RESULTS Using data from National Cardiovascular Data Registry(®) Implantable Cardioverter Defibrillator Registry(™) linked with Medicare claims data, we identified 25 180 patients ...

Journal: :Brazilian journal of anesthesiology 2014
Amy G Rapsang Prithwis Bhattacharyya

A pacemaking system consists of an impulse generator and lead or leads to carry the electrical impulse to the patient's heart. Pacemaker and implantable cardioverter defibrillator codes were made to describe the type of pacemaker or implantable cardioverter defibrillator implanted. Indications for pacing and implantable cardioverter defibrillator implantation were given by the American College ...

2015
Daniel B Kramer Laura A Hatfield Deepa McGriff Christopher R Ellis Melanie T Gura Michelle Samuel Linda Kallinen Retel Robert G Hauser

BACKGROUND As implantable cardioverter-defibrillator technology evolves, clinicians and patients need reliable performance data on current transvenous implantable cardioverter-defibrillator systems. In addition, real-world reliability data could inform postmarket surveillance strategies directed by regulators and manufacturers. METHODS AND RESULTS We evaluated Medtronic Sprint Quattro, Boston...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید